Morelli et al. Structure-activity relationships for some elastin-derived peptide chemoattractants. J. Peptide Res. vol. 49, No. 6, pp. 492-499 (Jun. 1997).* |
Zhou et al. Leukocyte Response Integrin and Integrin-Associated protein . . . J. Exp. Med. vol. 178, pp. 1165-1174 (Oct. 1993).* |
Alemáet al, “Differentiation of PC12 phaeochromocytoma cells induced by v-src oncogene”, Nature 316:557-559 (1985). |
Birchall et al, “Ro 32-0432, a Selective and Orally Active Inhibitor of Protein Kinase C Prevents T-Cell Activation”, J Pharmacol Exp Ther 268(2):922-929 (1994). |
Bradshaw et al, “Therapeutic potential of protein kinase C inhibitors”, Agents Actions 38:135-147 (1993). |
Dudek et al, “Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt”, Science 275:661-665 (1997). |
Franke et al, “P13K: Downstream AKTion Blocks Apoptosis”, Cell 88:435-437 (1997). |
Freedman et al, “Desensitization of G Protein-Coupled Receptors”, Recent Prog Horm Res 51:319-353 (1996). |
Glover et al, “Polo Kinase: The Choreographer of the Mitotic Stage?”, J Cel Biol 135(6)(2):1681-1684 (1996). |
Hanks et al, “The Eukaryotic Protein Kinase Superfamily”, The Protein Kinase Facts Book, vol. 1 (Hardie et al, eds), Academic Press, Chapter 2 (1995). |
Hanks et al, “The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification”, FASEB J 9:576-596 (1995). |
Hemmings et al, “Akt Signaling: Linking Membrane Events to Life and Death Decisions”, Science 275:628-631 (1997). |
Hubbard et al, “Crystal structure of the tyrosine kinase domain of the human insulin receptor”, Nature 372:746-753 (1994). |
Hughes AL, “Evolution of the src-Related Protein Tyrosine Kinases”, J Mol Evol 42:247-256 (1996). |
Inazu et al, “Purification and characterization of a novel dimeric 20 alpha-hydroxysteroid dehydrogenase from Tetrahymena pyriformis”, Biochem J 297:195-200 (1994). |
Kohn et al, “Expression of a Constitutively Active Akt Ser/Thr Kinase in 3T3-L1 Adipocytes Stimulates Glucose Uptake and Glucose Transporter 4 Translcoation”, J Biol Chem 271(49):31372-31378 (1996). |
Lovrić et al, “Activation of Mil/Raf protein kinases in mitotic cells”, Oncogene 12:1109-1116 (1996). |
Lange-Carter et al, “A Divergence in the MAP Kinase Regulatory Network Defined by MEK Kinase and Raf”, Science 260:315-318 (1993). |
Mason IJ, “The Ins and Outs of Fibroblast Growth Factors”, Cell 78:547-552 (1994). |
McKenna et al, “Atomic structure of the degraded procapsid particle of the bacteriophage G4: induced structural changes in the presence of calcium ions and functional implications,” J. Mol. Biol. 256:736-750 (1996). |
Mohammadi et al, “Structureo f the FGF Receptor Tyrosine Kinase Domain Reveals a Novel Autoinhibitory Mechanism”, Cell 86:577-587 (1996). |
Nishizuka Y, “Protein kinase C and lipid signaling for sustained cellular responses”, FASEB J 9:484-496 (1995). |
Petit G, Synthetic Peptides, vol 4., Amsterdam: Elsevier Sci. Pub. Co. pp 212, 223, 470 (1976). |
Simmons et al, “Identification of an Early-Growth Response Gene Encoding a Novel Putative Protein Kinase”, Mol Cel Biol 12:4164-4169 (1992). |
Taylor et al, “cAMP-dependent protein kinase defines a family of enzymes”, Phil Trans R Soc Lond B 340:315-324 (1993). |